Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1314-2026

Brevera Breast Biopsy System Disposable 9 Gauge Needle. Biopsy Instrument. Recall

Brevera Breast Biopsy System Disposable 9 Gauge Needle. Biopsy Instrument.

FDA recall Class II

Ongoing

FDA lists this Class II recall for Brevera Breast Biopsy System Disposable 9 Gauge Needle. Biopsy Instrument.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1314-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Dec 15, 2025
FDA report date
Feb 18, 2026
Quantity in commerce
681,870 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Brevera Breast Biopsy System Disposable 9 Gauge Needle. Biopsy Instrument.

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

Model No - BREVDISP09; UDI - 1540045512863; All Lots within expiry.

View the original FDA recall notice

Why was this product recalled?

Presence of particulates in affected devices that can be deposited into breast tissue during use.

What actions did Hologic, Inc. take?

An URGENT FIELD SAFETY NOTICE (REMOVAL) was mailed to consignees on 1/2/26. The notification instructs consignees to quarantine affected devices and return them through IQVIA per the instructions provided on the Recall Response Form. The recall notification should be forwarded within consignee locations to users and to any facility to which product was further distributed. A copy of the recall notification is to be posted for awareness at consignee locations. Questions can be directed to [email protected] or by phone at 1-877-371-4372. An updated FIELD TECHNICAL BULLETIN dated May 2026 was distributed to consignees. This technical bulletin provides guidance to healthcare providers on how to utilize the Brevera Breast Biopsy System without the use of the Brevera 9 Gauge Biopsy Needle. Questions can be directed to [email protected] or by phone at 1-877-371-4372.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology